Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taste preference and tolerance comparison of PEG 4000 versus PEG 3350 in children with constipation
NL-OMON30493Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2007
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, double-blind trial in functional constipation (FC) comparing PEG 4000 with PEG 3350 (2 arms). Primary endpoints: PEG preference at baseline, Constipation outcome and 1 more. Planned start Jun 2007; status: not yet recruiting.
02
Drugs
macrogol 4000polyethylene glycol 3350
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on NL-OMON30493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30493.